1098 related articles for article (PubMed ID: 18591502)
1. Economic cost of Guillain-Barré syndrome in the United States.
Frenzen PD
Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
[TBL] [Abstract][Full Text] [Related]
2. The burden of illness associated with renal cell carcinoma in the United States.
Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
[TBL] [Abstract][Full Text] [Related]
3. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
4. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
Molinari NA; Ortega-Sanchez IR; Messonnier ML; Thompson WW; Wortley PM; Weintraub E; Bridges CB
Vaccine; 2007 Jun; 25(27):5086-96. PubMed ID: 17544181
[TBL] [Abstract][Full Text] [Related]
5. The economic burden of smoking in California.
Max W; Rice DP; Sung HY; Zhang X; Miller L
Tob Control; 2004 Sep; 13(3):264-7. PubMed ID: 15333882
[TBL] [Abstract][Full Text] [Related]
6. The economic burden of prostate cancer, California, 1998.
Max W; Rice DP; Sung HY; Michel M; Breuer W; Zhang X
Cancer; 2002 Jun; 94(11):2906-13. PubMed ID: 12115378
[TBL] [Abstract][Full Text] [Related]
7. The economic burden of depression in 1990.
Greenberg PE; Stiglin LE; Finkelstein SN; Berndt ER
J Clin Psychiatry; 1993 Nov; 54(11):405-18. PubMed ID: 8270583
[TBL] [Abstract][Full Text] [Related]
8. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
Phanthunane P; Whiteford H; Vos T; Bertram M
J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
[TBL] [Abstract][Full Text] [Related]
9. An economic evaluation of asthma in the United States.
Weiss KB; Gergen PJ; Hodgson TA
N Engl J Med; 1992 Mar; 326(13):862-6. PubMed ID: 1542323
[TBL] [Abstract][Full Text] [Related]
10. The economic consequences of irritable bowel syndrome: a US employer perspective.
Leong SA; Barghout V; Birnbaum HG; Thibeault CE; Ben-Hamadi R; Frech F; Ofman JJ
Arch Intern Med; 2003 Apr; 163(8):929-35. PubMed ID: 12719202
[TBL] [Abstract][Full Text] [Related]
11. Hospital admissions for Guillain-Barré syndrome in the United States, 1993-2004.
Frenzen PD
Neuroepidemiology; 2007; 29(1-2):83-8. PubMed ID: 17925599
[TBL] [Abstract][Full Text] [Related]
12. Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis-United States, 2003.
Ekwueme DU; Chesson HW; Zhang KB; Balamurugan A
Cancer; 2008 Nov; 113(10 Suppl):2936-45. PubMed ID: 18980277
[TBL] [Abstract][Full Text] [Related]
13. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.
Merkesdal S; Ruof J; Huelsemann JL; Mittendorf T; Handelmann S; Mau W; Zeidler H
Arthritis Rheum; 2005 Apr; 53(2):234-40. PubMed ID: 15818718
[TBL] [Abstract][Full Text] [Related]
14. Cost of cardiovascular diseases in the United Kingdom.
Luengo-Fernández R; Leal J; Gray A; Petersen S; Rayner M
Heart; 2006 Oct; 92(10):1384-9. PubMed ID: 16702172
[TBL] [Abstract][Full Text] [Related]
15. Indirect cost of ischemic heart disease to employers.
Guico-Pabia CJ; Murray JF; Teutsch SM; Wertheimer AI; Berger ML
Am J Manag Care; 2001 Jan; 7(1):27-34. PubMed ID: 11209448
[TBL] [Abstract][Full Text] [Related]
16. A preliminary study into the economic burden of cerebral palsy in China.
Wang B; Chen Y; Zhang J; Li J; Guo Y; Hailey D
Health Policy; 2008 Aug; 87(2):223-34. PubMed ID: 18282633
[TBL] [Abstract][Full Text] [Related]
17. Costs and quality of life of multiple sclerosis in Switzerland.
Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
[TBL] [Abstract][Full Text] [Related]
18. Direct and indirect costs of asthma in Canada, 1990.
Krahn MD; Berka C; Langlois P; Detsky AS
CMAJ; 1996 Mar; 154(6):821-31. PubMed ID: 8634960
[TBL] [Abstract][Full Text] [Related]
19. Economic burden of moderate to severe plaque psoriasis in Canada.
Levy AR; Davie AM; Brazier NC; Jivraj F; Albrecht LE; Gratton D; Lynde CW
Int J Dermatol; 2012 Dec; 51(12):1432-40. PubMed ID: 23171010
[TBL] [Abstract][Full Text] [Related]
20. A cost analysis of Behcet's syndrome in Turkey.
Sut N; Seyahi E; Yurdakul S; Senocak M; Yazici H
Rheumatology (Oxford); 2007 Apr; 46(4):678-82. PubMed ID: 17121761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
